Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Yap YS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
André F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: Fabrice.ANDRE@gustaveroussy.fr., Solovieff N; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Su F; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., Neven P; Multidisciplinary Breast Centre, Universitair Ziekenhuis Leuven, Leuven, Belgium., Yap YS; National Cancer Centre Singapore, Singapore., Tripathy D; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Slamon D; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Chia S; British Columbia Cancer Agency, Vancouver, BC, Canada., Joshi M; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA., Chakravartty A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Lteif A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Taran T; Novartis Pharma AG, Basel, Switzerland., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX, USA. Electronic address: Carlos.Arteaga@UTSouthwestern.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep 21. Date of Electronic Publication: 2024 Sep 21.
Autor:
Noguchi E; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yamanaka T; Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan., Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Yamamoto N; Department of Breast Surgery, Chiba Cancer Center Hospital, Chiba, Japan., Chung CF; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Chang DY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim GM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Iwasa T; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan., Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Watanabe K; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Tanabe Y; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan., Kang SY; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea., Yasojima H; Departments of Surgery and Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan., Aogi K; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Tokunaga E; Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Sim SH; Center for Breast Cancer, National Cancer Center, Goyang-Si, Republic of Korea., Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Matsumoto K; Hyogo Cancer Center Division of Medical Oncology, Akashi, Japan., Tseng LM; Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan., Umeyama Y; Pfizer R&D Japan, Tokyo, Japan., Sudo K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Hata T; International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan., Kuchiba A; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan., Shibata T; Biostatistics Section, Clinical Research Support Office National Cancer Center Hospital/Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan., Nakamura K; Department of International Clinical Development, National Cancer Center Hospital, Tokyo, Japan., Fujiwara Y; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Tamura K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. kyonemor@ncc.go.jp.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Aug 22; Vol. 10 (1), pp. 76. Date of Electronic Publication: 2024 Aug 22.
Autor:
Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Mahidin EIBM; Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Azim H; School of Medicine, Cairo University, Cairo, Egypt., Eralp Y; Acıbadem Research Institute of Senology, Acıbadem University, Istanbul, Turkey., Yap YS; National Cancer Centre Singapore, Singapore., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Rihani J; Independent Patient Advocate, Amman, Jordan., Gokmen E; Ege University Faculty of Medicine, Izmir, Turkey., El Bastawisy A; National Cancer Institute, Cairo University, Giza, Egypt., Karadurmus N; Gülhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey., Lim YN; Sarawak General Hospital, Kuching, Sarawak, Malaysia., Lim CS; Hospital Sultan Ismail, Johor Bharu, Johor Darul Ta'zim, Malaysia., Duc LT; National Cancer Hospital, Hanoi, Vietnam., Chung WP; National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Babu KG; HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India., Penkov K; Private Medical Institution Euromedservice, St Petersburg, Russian Federation., Bowles J; Novartis Pharma AG, Basel, Switzerland., Alfaro TD; Novartis Pharma AG, Basel, Switzerland., Wu J; Novartis Pharmaceuticals Corporation, East Hanover, NJ., Gao M; Novartis Pharma AG, Basel, Switzerland., Slimane K; Novartis Pharma AG, Basel, Switzerland., El Saghir NS; American University of Beirut Medical Center, Beirut, Lebanon.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 10; Vol. 42 (23), pp. 2812-2821. Date of Electronic Publication: 2024 May 21.
Autor:
Tan RYC; 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; 2Duke-NUS Medical School, Singapore., Ong WS; 3Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore., Lee KH; 4Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Park S; 5Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of South Korea., Iqbal J; 2Duke-NUS Medical School, Singapore.; 6Division of Pathology, Singapore General Hospital, Singapore., Park YH; 5Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of South Korea.; 7Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea., Lee JE; 8Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea., Yu JH; 8Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of South Korea., Lin CH; 9Department of Medical Oncology, National Taiwan University Hospital, Cancer Center Branch, Taipei, Taiwan., Lu YS; 10Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Ono M; 11Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Ueno T; 12Breast Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Naito Y; 13Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Onishi T; 14Department of Breast Surgery, National Cancer Center Hospital East, Kashiwa, Japan., Lim GH; 15Breast Department, KK Women's and Children's Hospital, Singapore.; 16SingHealth Duke-NUS Breast Centre, Singapore., Tan SM; 16SingHealth Duke-NUS Breast Centre, Singapore.; 17Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore., Lee HB; 18Department of Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Koh J; 19Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea., Han W; 18Department of Surgery, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Im SA; 4Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Tan VKM; 2Duke-NUS Medical School, Singapore.; 16SingHealth Duke-NUS Breast Centre, Singapore.; 20Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.; 21Department of Breast Surgery, Singapore General Hospital, Singapore., Phyu N; 22Department of Cancer Informatics, National Cancer Centre Singapore, Singapore., Wong FY; 2Duke-NUS Medical School, Singapore.; 22Department of Cancer Informatics, National Cancer Centre Singapore, Singapore.; 23Division of Radiation Oncology, National Cancer Centre Singapore, Singapore., Tan PH; 24Luma Medical Centre, Singapore., Yap YS; 1Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; 2Duke-NUS Medical School, Singapore.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 May 14; Vol. 22 (2D). Date of Electronic Publication: 2024 May 14.
Autor:
Prat A; Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; IOB-Quironsalud, Barcelona, Spain., Solovieff N; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., André F; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., O'Shaughnessy J; Texas Oncology-Baylor University Medical Center and The US Oncology Research Network, Dallas, Texas., Cameron DA; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, United Kingdom., Janni W; Department of Gynecology, University of Ulm, Ulm, Germany., Sonke GS; Netherlands Cancer Institute/Borstkanker Onderzoek Groep Study Center, Amsterdam, the Netherlands., Yap YS; National Cancer Centre Singapore, Singapore., Yardley DA; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee., Partridge AH; Dana-Farber Cancer Institute, Boston, Massachusetts., Thuerigen A; Novartis Pharma AG, Basel, Switzerland., Zarate JP; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Lteif A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Su F; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey., Carey LA; University of North Carolina, Chapel Hill, North Carolina.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 793-802.